An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer (Q33412123)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer |
scientific article |
Statements
An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer (English)
Michael A Carducci
Walter M Stadler
David J Vaughn
Guru Sonpavde
Nicholas J Vogelzang
Scott T Tagawa
Daniel P Petrylak
Peter Rosen
Chia-Chi Lin
John Mahoney
Sanjiv Modi
Marc S Ernstoff
Alexander Spira
Korinna Pilz
Richard Vinisko
Charles Schloss
Holger Fritsch
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference